Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maartje I Kester

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Practical Neurology|July 18, 2009
Dementia: the bare essentialsMaartje I Kester, Philip Scheltens
Neurobiology of Aging|October 31, 2008
Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairmentMaartje I Kester, Nicolaas A Verwey, Evert J van Elk, et al.
International Journal of Alzheimer'S Disease|October 12, 2010
Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International WorkshopCharlotte E Teunissen, Niek A Verwey, Maartje I Kester, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's diseaseMaartje I Kester, Wiesje M van der Flier, Gorana Mandic, et al.
Clinical Chemistry and Laboratory Medicine|September 28, 2011
Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samplesMaartje I Kester, Wiesje M van der Flier, Allerdien Visser, et al.
Neurobiology of Aging|September 15, 2009
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotypeMaartje I Kester, Nicolaas A Verwey, Evert J van Elk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease studyWesley Jongbloed, Maartje I Kester, Wiesje M van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by ageMaartje I Kester, Marinus A Blankenstein, Femke H Bouwman, et al.
The Journal of Infection|November 18, 2006
Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitisAnnemarie E Brouwer, Asna A Siddiqui, Maartje I Kester, et al.
Journal of Alzheimer'S Disease : JAD|May 1, 2013
Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriersFlora H Duits, Maartje I Kester, Peter G Scheffer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Practical Neurology|July 18, 2009
Dementia: the bare essentialsMaartje I Kester, Philip Scheltens
Neurobiology of Aging|October 31, 2008
Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairmentMaartje I Kester, Nicolaas A Verwey, Evert J van Elk, et al.
International Journal of Alzheimer'S Disease|October 12, 2010
Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International WorkshopCharlotte E Teunissen, Niek A Verwey, Maartje I Kester, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's diseaseMaartje I Kester, Wiesje M van der Flier, Gorana Mandic, et al.
Clinical Chemistry and Laboratory Medicine|September 28, 2011
Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samplesMaartje I Kester, Wiesje M van der Flier, Allerdien Visser, et al.
Neurobiology of Aging|September 15, 2009
Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotypeMaartje I Kester, Nicolaas A Verwey, Evert J van Elk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2012
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease studyWesley Jongbloed, Maartje I Kester, Wiesje M van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2009
CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by ageMaartje I Kester, Marinus A Blankenstein, Femke H Bouwman, et al.
The Journal of Infection|November 18, 2006
Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitisAnnemarie E Brouwer, Asna A Siddiqui, Maartje I Kester, et al.
Journal of Alzheimer'S Disease : JAD|May 1, 2013
Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriersFlora H Duits, Maartje I Kester, Peter G Scheffer, et al.
Pageof 3